Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

28. November 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 2914


	Artikel 1 - 20 / 58273

	Tumor Extracellular Vesicle Digital Scoring Assays for Cancer Detection and Monitoring. Precis Chem Lee J, Zhao C, Yang J, Jonas SJ, Agopian V, You S, Posadas E, Yang JD, Zhu Y, Tseng HR. PMID: 41312082 [PubMed]
	Cytological Features of Pancreatic Medullary Carcinoma Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Aspiration. Diagn Cytopathol Okawa U, Mizuguchi K, Okuda M, Mori T, Ikeda H. PMID: 41310971 [PubMed - as supplied by publisher]
	Macrophages in obesity-related breast cancer: mechanistic insights and therapeutic opportunities. Breast Cancer Res Dong H, Zhou M, Sun Q, Ren Y, Ma L. PMID: 41310829 [PubMed - in process]
	Primary pancreatic signet ring cell carcinoma: molecular mechanisms and advances in clinical diagnosis and treatment. World J Surg Oncol Zhang J, Huang H, Tang B, Hu X, Ming Z, Wan D, Qu Q. PMID: 41310663 [PubMed - as supplied by publisher]
	Frailty as a predictor of postoperative outcomes in older gastroesophageal cancer patients: a systematic review and meta-analysis. BMC Geriatr Zhang F, Yan Y, Li B, Ge C. PMID: 41310498 [PubMed - as supplied by publisher]
	Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges. Signal Transduct Target Ther Choucair K, Imtiaz H, Uddin MH, Nagasaka M, Al-Hallak MN, Philip PA, El-Rayes B, Pasche BC, Azmi AS. PMID: 41309533 [PubMed - indexed for MEDLINE]
	Actionable mutations in pancreatic cancer: where targeted therapies are making a difference. BMJ Open Gastroenterol Fivaz M, Bornand A, Corro C, Koessler T, Genoud V. PMID: 41309265 [PubMed - indexed for MEDLINE]
	Tumor-infiltrating lymphocyte aggregation refines prognosis in patients with hepatocellular carcinoma. Lab Invest Zhang Z, Lian Y, Wu Y, Weng Z, Ye J, Zhang S, Li L, Bai Y. PMID: 41308747 [PubMed - as supplied by publisher]
	Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study. Lancet Oncol Qin S, Gu S, Chan SL, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Xu L, Yuan X, Li D, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Du J, Shi W, Cheng AL, Kaseb A, Vogel A, CARES-310 Study Group. PMID: 41308676 [PubMed - indexed for MEDLINE]
	Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy. Int J Nanomedicine Lei SY, Qin H, Liu S, Sheng J. PMID: 41306662 [PubMed - indexed for MEDLINE]
	Consensus on the Management of Liver Injury Associated with Targeted Drugs and Immune Checkpoint Inhibitors for Hepatocellular Carcinoma (Version 2024). J Clin Transl Hepatol Zhao S, Li J, Liu L, Huang S, Gao Y, Liu M, Chen Y, Wei L, Jia J, You H, Duan Z, Zhuang H, Liu J, Xu X, Nan Y, Chinese Society of Hepatology, Chinese Medical Association. PMID: 41306369 [PubMed]
	The effect of circulating CD4+ and CD8+ T cells on the prognosis in advanced postoperative pancreatic adenocarcinoma patients who received chemotherapy. Medicine (Baltimore) Chang Q, Fan H, Si W, Mao J. PMID: 41305823 [PubMed - indexed for MEDLINE]
	Histopathological Scoring of Renal Injury in an Experimental Model of Acute Pancreatitis Caused by Karwinskia humboldtiana Fruit: Exploring Its Potential Utility in the Treatment of Pancreatic Cancer. Pharmaceuticals (Basel) Esparza-Rodríguez N, Solís-Flores NJ, Medellín-Zapata GG, Segoviano-Ramírez JC, Carcaño-Díaz K, Ortega-Martínez M, Jaramillo-Rangel G, García-Juárez J. PMID: 41304897 [PubMed]
	SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer. Medicina (Kaunas) Akar H, Ekinci F, Erdo, . PMID: 41303856 [PubMed - indexed for MEDLINE]
	Clinical Management and Prognostic Outcomes of Pancreatic Neuroendocrine Tumors: Insights from a Tertiary Care Center. Medicina (Kaunas) Diculescu RI, Stroie T, Istr, Croitoru AE, Gheorghe C, Bra, Dumitra, Eftimie MA, , Poian. PMID: 41303791 [PubMed - indexed for MEDLINE]
	An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors. Int J Mol Sci Choucair K, Odabashian R, Reddy SN, Azmi AS, Saif MW. PMID: 41303577 [PubMed - indexed for MEDLINE]
	mRNA-Based Neoantigen Vaccines in Pancreatic Ductal Adenocarcinoma (PDAC)-A Promising Avenue in Cancer Immunotherapy. Int J Mol Sci Kabut J, Stopyra M, Nafalska N, St, Miciak M, Jezierza, Furgo, Feret K, Gisterek-Grocholska I. PMID: 41303473 [PubMed - indexed for MEDLINE]
	Clinical and Molecular Characteristics of KRAS Codon-Specific Mutations in Advanced Pancreatic Ductal Adenocarcinoma with Prognostic and Therapeutic Implications. Int J Mol Sci Cho D, Shin K, Hong TH, Lee SH, Kim Y, Kim IH, Hong SH, Lee M, Park SJ. PMID: 41303394 [PubMed - indexed for MEDLINE]
	Hypoxia-Induced Extracellular Vesicles and Non-Coding RNAs in Cancer: A Systematic Review of Tumor Dynamics and Therapeutic Implications in Preclinical Animal Models. Biomedicines Afonso JPR, Taverna S, Pinsino A, Cammarata G, Andraus RAC, Silva IO, Silva CHM, Oliveira CS, Oliveira RF, Oliveira DAAP, Guedes OA, Maia LP, Junior WRF, Ilias EJ, Uriarte JJ, Insalaco G, Oliveira LVF. PMID: 41301888 [PubMed]
	Pancreatic Metastases from Cervical Squamous Cell Carcinoma: Systematic Review of the Literature and Case Report. Biomedicines Qian-Zhang S, Romero-Triana D, Meliga C, Domínguez-Prieto V, López-Botet Zulueta B, Martín-Sánchez M, Jiménez-Galanes S, Rojo-Villardón E, Villarejo-Campos P. PMID: 41301806 [PubMed]

Artikel 1 - 20 / 58273

Seite 1 von 2914



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung